Overview

Familial Atherosclerosis Treatment Study

Status:
Completed
Trial end date:
1989-08-01
Target enrollment:
Participant gender:
Summary
To compare the effects of two intensive lipid-lowering regimens with conventional therapy on coronary atherosclerosis as assessed by arteriography.
Phase:
Phase 3
Details
Lead Sponsor:
University of Washington
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Colestipol
Dihydromevinolin
L 647318
Lovastatin
Niacin
Niacinamide
Nicotinic Acids